Vicinity Energy Incorporates Green Loan Principles to Support Investment Funding in Green Districts
BOSTON–(BUSINESS WIRE)–#BOSpoli—Vicinity Energy, a decarbonization leader with the nation’s largest portfolio of district energy systems,…
Month: August 2022
NineDot Energy Launches Community-scale Bronx Battery Energy Storage Site
The NineDot site, including the first Tesla Megapack system deployed in New York City, is…
New Research: CX Innovation Stalls as Contact Centers Fail at the Fundamentals
UJET Partners with CCMA to Identify and Eliminate Barriers in Contact Center Innovation SAN FRANCISCO–(BUSINESS…
VitalConnect Announces Addition of Heather Getz to Board of Directors
Getz adds 25 Years of Financial and Healthcare Leadership to Growing Company SAN JOSE, Calif.–(BUSINESS…
Duncan Stubbs Grows Team with New Partner Ben Browder
Browder joins firm from Hunton Andrews Kurth and will drive mass litigation efforts to maximize…
Liberty Street Advisors Private Shares Fund Clears $1 Billion Milestone
The Private Shares Fund’s AUM has nearly quadrupled since December 2020 GrubMarket, Tradeshift and SpaceX…
Global Tech and Talent Solutions Provider MSH Expands Presence to Dallas
— Regional Economic Growth Fuels Demand for Top-Notch Tech Talent — — Companies Try to…
Onfleet Welcomes Kristen Jones as Chief Revenue Officer
Jones will leverage proven record of scaling B2B SaaS companies and CRO experience to help…
BostonGene Announces Publication in Cancer Cell Revealing the Development of a Machine Learning Cellular Deconvolution Algorithm that Accurately Reconstructs the Tumor Microenvironment and Supports Oncology Clinical Decision-making
WALTHAM, Mass.–(BUSINESS WIRE)–BostonGene today announced the online publication of the manuscript, “Precise reconstruction of the…
Manifest Support for Microsoft Azure Remote Rendering Now Available from Taqtile
Realistic 3D Models and Detailed Digital Twins Now Available to Deskless Workers on HoloLens 2…
ISG recognizes HARMAN DTS as a ‘Leader’ in the Provider Lens™ Internet of Things Services and Solutions 2022 Report
Recognized as a leader in Implementation and Integration, Managed Services, Mobile Asset Tracking and Management,…
CURE Pharmaceutical Provided Full Corporate Update on Recent Shareholder Call
OXNARD, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) — CURE Pharmaceutical Holding Corp. (OTC: CURR) (“CURE”),…
Ceapro Inc. Announces Publication of Positive Results for PGX-Processed Alginates Impregnated with CoQ10 in The Journal of Supercritical Fluids
– PGX Technology continues to demonstrate the ability to generate superior novel bioactive delivery systems…
SCYNEXIS to Report Second Quarter 2022 Financial results and Provide a Corporate Update on August 15
JERSEY CITY, N.J., Aug. 09, 2022 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology…
SELLAS Life Sciences’ GFH009 Demonstrates Cancer Cell Growth Inhibition in Preclinical In Vitro Studies in Solid Cancer and Acute Myeloid Leukemia Cell Lines
– Results Demonstrate Significant Anti-Tumor Effects on All Selected Cell Lines – – In Three…
Third Harmonic Bio Appoints Thomas M. Soloway to its Board of Directors
CAMBRIDGE, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) — Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical…
Key Collaboration and Distribution Agreement Signed With Major Partner To Advance Sofwave™ Sales In China’s Growing $29 Billion Aesthetic Medicine Market
Partnership is with HTDK Group, wholly owned by Warburg Pincus HTDK Group is a leading…
Veru Announces Presentation of Phase 3 Study of Sabizabulin for the Treatment of Hospitalized COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome at the 11th International Conference on Emerging Infectious Diseases (ICEID) on August 7-10, 2022
MIAMI, Aug. 09, 2022 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused…
T2 Biosystems to Explore Potential to Develop Rapid Molecular Diagnostic Test for Monkeypox Virus
LEXINGTON, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in…
Artelo Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update
CAReS Study Evaluating ART27.13 in Cancer Anorexia Progresses to Fourth Cohort ART26.12 Program to Target…